3 treatment centers
Casa Quetzal
San Francisco, California
Fort Help Mission
San Francisco, California
Foundations San Francisco
San Francisco, California
No centers match
Try a different search term
3 SAMHSA-listed treatment centers in San Francisco, California. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
San Francisco, California
San Francisco, California
San Francisco, California
Try a different search term
San Francisco, California has 3 SAMHSA-verified addiction treatment centers offering a range of evidence-based programs. California faces a severe fentanyl and methamphetamine crisis, with over 10,000 overdose deaths annually.
Available programs in San Francisco include 1 residential/inpatient rehab program, 2 outpatient programs, 1 dual diagnosis (co-occurring mental health) program, and 1 medical detox facility. All listed facilities are sourced directly from the federal SAMHSA National Registry of Substance Abuse Treatment Services.
Most treatment centers in San Francisco accept Medicaid, Medicare, and major private insurance plans including Aetna, Cigna, BlueCross BlueShield, and UnitedHealthcare. Under the Affordable Care Act (ACA) and the Mental Health Parity Act, insurance providers are required to cover substance use disorder treatment at the same level as other medical conditions. Call (319) 271-2077 for a free insurance verification — no obligation, completely confidential.
When selecting from the 3 treatment options in San Francisco, consider: the type and severity of the substance use disorder, whether co-occurring mental health conditions require dual diagnosis treatment, your insurance coverage and financial situation, the distance from home and your support network, and the facility's accreditation and evidence-based approach. Our helpline is available 24/7 at (319) 271-2077 to help match you with the right program — free and confidential.
Free, confidential assistance matching you with the right program in San Francisco.
Treatment centers in San Francisco accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Most San Francisco treatment providers accept commercial insurance through one of three arrangements: in-network (negotiated rates, lower patient out-of-pocket), out-of-network with benefits (some coverage, higher patient cost-sharing), or self-pay (cash arrangement, often with payment plans). Medicaid coverage varies by individual provider and program type — some facilities accept Medicaid for outpatient but not residential, others accept only commercial. Medicare Part A covers inpatient residential when medically necessary; Part B covers outpatient care including MAT prescribing visits.
Personality disorders — particularly borderline personality disorder and antisocial personality disorder — are common in addiction-treatment populations and shape both treatment course and outcome. San Francisco programs increasingly incorporate Dialectical Behavior Therapy (DBT) skills training, mentalization-based therapy, and structured approaches to interpersonal-effectiveness building. Treatment for personality-disorder patterns typically requires longer treatment episodes than substance-only presentations and ongoing therapy well beyond the formal program completion.
Residents of San Francisco accessing addiction treatment encounter a treatment system shaped by three federal frameworks: the Mental Health Parity and Addiction Equity Act (insurance parity), the ACA (substance-use disorder treatment as Essential Health Benefit), and 42 CFR Part 2 (heightened confidentiality of substance-use records). These protections apply universally — patients in San Francisco have the same legal foundations as patients anywhere in California or the broader U.S. The differences across providers are clinical (modalities, staffing, programming) and financial (insurance networks, self-pay terms).
Sober living environments (SLEs) in San Francisco and surrounding areas bridge residential treatment and full independent living. SLE quality varies considerably; the National Alliance for Recovery Residences (NARR) provides a certification framework with four quality levels (peer-run to clinically integrated). Reputable San Francisco-area SLEs require drug testing, mutual-support meeting attendance, progressive responsibility (employment, household contribution), and structured-day adherence. Typical stay length is 3-12 months, longer for patients with severe addiction histories.
Family involvement in San Francisco program admission typically begins with the admissions call itself — many patients seeking treatment have a family member or partner initiating the contact. Most facilities allow family conversations during the admission process (subject to 42 CFR Part 2 confidentiality), schedule family education or therapy sessions early in treatment, and explicitly involve family in discharge planning. Family-system engagement correlates with better treatment outcomes across the literature.
Withdrawal severity is the first clinical screening factor for treatment entry in San Francisco. Patients showing or at risk for moderate-to-severe alcohol or benzodiazepine withdrawal typically require medically managed detox before transitioning to lower-intensity care — untreated severe alcohol withdrawal carries 5% mortality and severe benzodiazepine withdrawal can be fatal. Opioid use patients face a different pathway: detox-only is rarely effective for opioid use disorder, and evidence-based protocols typically initiate medication-assisted treatment (buprenorphine or methadone) during the stabilization phase.
Withdrawal from alcohol or benzodiazepines can be medically dangerous and should not be attempted at home by San Francisco residents with daily or heavy use. Signs of severe withdrawal requiring emergency care include seizures, hallucinations, severe tremor, disorientation, fever, and autonomic instability. Delirium tremens (DTs) carries 5% mortality without treatment and occurs in 3-5% of heavy alcohol users withdrawing. Medical detox at a licensed San Francisco facility is the standard of care for these presentations.